Endocrine Abstracts

Introduction: Androgen deprivation therapy (ADT) is widely used around the world for the treatment various stages of prostate cancer. Androgen deprivation therapy (ADT) in men with prostate cancer (PCa) increased chance of developing metabolic disorders in insulin sensitivity, lipid levels, glucose metabolism, body composition (increases fat accumulation concurrently with a decrease in lean mass). These changes are the risk factors for the development of adverse cardiovascular...